期刊文献+

非透析慢性肾脏病患者脉搏波传导速度与尿蛋白量的相关性研究 被引量:1

下载PDF
导出
摘要 目的通过测量非透析慢性肾脏病(CKD)(1~5期)患者的脉搏波传导速度(PWV)及24 h尿蛋白定量,分析PWV和24 h尿蛋白定量的关系。方法横断面研究住院患者118例,均为诊断明确的非透析CKD患者,按照尿蛋白定量水平(〈1.0 g/24 h;1.0~3.5 g/24 h;≥3.5 g/24 h)分为三组:A组40例,B组40例,C组38例;健康体检者58例为健康对照组。记录患者性别、年龄、身高、体重、吸烟状况、血压、空腹血糖、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、肾功能。通过简化的肾脏病膳食改良公式计算肾小球滤过率估计值(e GFR),测定PWV值及24 h尿蛋白定量。结果与健康对照组比较,A、B、C组患者PWV值明显增高,差异具有统计学意义(P〈0.01);与A组比较,B、C组患者的PWV值明显增高,差异具有统计学意义(P〈0.01);与B组比较,C组患者PWV值明显增高,差异具有统计学意义(P〈0.01);Spearman相关分析显示,年龄、糖尿病、高血压、HDL-C、LDL-C、e GFR和尿蛋白定量为PWV的独立危险因素,差异具有统计学意义(P〈0.05)。结论影响非透析慢性肾脏病患者的脉搏波传导速度的因素有年龄、糖尿病、高血压、e GFR和尿蛋白定量,降低尿蛋白会改善患者的脉搏波传导速度。
机构地区 福建省立医院
出处 《中国实用医药》 2015年第9期47-49,共3页 China Practical Medicine
基金 福建省自然科学基金项目(项目编号:2011j01134)
  • 相关文献

参考文献11

  • 1Foley RN, Parfrey PS, Samak MJ. Clinical epidemiolegy of cardiovascular disease in chronic renal disease. Am J Kidney Dis, 1998, 32(5 Suppl 3):S112-S119.
  • 2Cohn JN, Duprez DA, Grandits GA, et al. Arterial elasticity as part of a comprehensive assessment of cardiovascular risk and drug treatment. Hypertension, 2005, 46(1):217-220.
  • 3National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation classification, and stratification. Am J Kidney Dis, 2002, 39 (2 suppl 1):S1-S266.
  • 4郭太林,朱鹏立,林帆,余惠珍,洪富源,张丽.非透析慢性肾脏病患者肾小球滤过率的评估值与动脉硬化的相关性[J].中国动脉硬化杂志,2012,20(10):911-914. 被引量:6
  • 5Levey AS, Greene T, Kusek J, et al. A simplified equation to predict GFR from serum creatinine. J Am Soc Nephrol, 2000(11): 155A.
  • 6Levey AS, Atkins R, Coresh J, et al. Chronic kidney disease as a global public health problem:approaches and initiatives-aposition statement from Kidney Disease Improving Global Outcomes. Kidney Int, 2007, 72(3):247-259.
  • 7Chonehol M, Goldenbery I, Moss A J, et al. Risk factors for sudden cardiac death in patients with chronic renal insufficiency and left ventrieular dysfunction. Am J Nephrol, 2007, 27(1):7-14.
  • 8Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol, 2010, 55(13):1318-1327.
  • 9Lemos MM, Jancikic AD, Sanches FM, et al. Pulse wave velocity-a useful tool for cardiovascular surveillance in pre-dialysis patients. Nephrol Dial Transplant, 2007, 22(12):3527-3532.
  • 10Ohya Y, Iseki K, Iseki C, et al. Increased pulse wave velocity is associated with low creatinine clearance and proteinuria in a screened cohort. Am J Kidney Dis, 2006, 47(5):790-797.

二级参考文献30

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3044
  • 2McCullough PA, Jurkovitz CT, Pergola PE, et al. Independent components of chronic kidney disease as a cardiovascular risk state: Result from the Kidney Early Evaluation Program (KEEP)EJ]. Arch Intern Med, 2007, 167:1122-1129.
  • 3Cohn JN, Dup rezDA, Grandits GA, et al. Arterial elasticity as part of a comprehensive assessment of cardiovaseular risk and drug treatment[J].Hypertension, 2005,46:217-220.
  • 4Brier M, Bozec E, Laurent S, et al. Arterial stiffness and enlargement in mild-to-moderate chronic kidney disease [J]. Kidney Int, 2006,69:350-357.
  • 5London GM, Marchais SJ, Safar ME, et al. Aortic and large artery compliance in end-stage renal failure[J].Kidney Int, 1990,37:137-142.
  • 6Sipil? K, Koivistoinen T, Moilanen L, et al. Metabolic syndrome and arterial stiffness: the Health 2000 Survey [J]. Metabolism, 2007,56:320-326.
  • 7Stancanelli B, Malatino LS, Malaponte G, et al. Pulse pressure is an independent predictor of aortic stiffness in patients with mild to moderate chronic kidney disease [J]. Kidney Blood Press Res, 2007,30:283-288. Epub.
  • 8Zieman SJ, Melenovsky V, Kass DA, et al. Mechanisms, pathophysiology, and therapy of arterial stiffness[J]. Arterioscler Thromb Yasc Biol, 2005,24:27-34.
  • 9Kalousova M, Hodkova M, Kazderova M, et al. Soluble receptor for advanced glycation end products in patients with decreased renal function[J]. Am J Kidney Dis, 2006,47:406- 411.
  • 10Jesmin S, Sakuma I, Hattori Y, et al. Role of angiotensin Ⅱ in altered expression of molecules responsible for coronary matrix remodeling in insulin-resistant diabetic rats[J]. Arterioseler Thromb Vasc Biol, 2003,4:?8-85.

共引文献7

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部